Literature DB >> 9247304

Induction of senescence in human malignant glioma cells by p16INK4A.

L Uhrbom1, M Nistér, B Westermark.   

Abstract

p16INK4A is a G1-specific cell cycle inhibitor which maps to human chromosome 9p21, a region frequently mutated or deleted in cancer cell lines and primary tumors. In glioblastomas the frequency of homozygous deletions is 40-70% making it one of the most common mutations in this tumor type. We have analysed the significance of the loss of this gene in gliomas by introducing the cDNA for p16INK4A into the human glioma cell line U-1242 MG which has a deleted CDKN2 locus. We used the tetracycline repressible vector system and obtained two stably transfected clones that expressed p16INK4A upon induction. p16INK4A expression caused a G1 arrest and enlargement of the cells similar to that of senescent cells. When staining for Senescence-Associated beta-galactosidase activity, described to be specific for senescent cells, we could show that the enlarged cells specifically gave a positive staining reaction. This senescence phenotype was dependent on the continuous expression of p16INK4A since it was reversed upon reintroduction of tetracycline suppression. Thus, the induced expression of p16INK4A in these glioma cells reverted their immortal phenotype and caused an immediate cellular senescence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247304     DOI: 10.1038/sj.onc.1201227

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  PML is induced by oncogenic ras and promotes premature senescence.

Authors:  G Ferbeyre; E de Stanchina; E Querido; N Baptiste; C Prives; S W Lowe
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

2.  Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes.

Authors:  Benjamin W Darbro; Galen B Schneider; Aloysius J Klingelhutz
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

3.  Telomere shortening is an in vivo marker of myocyte replication and aging.

Authors:  J Kajstura; B Pertoldi; A Leri; C A Beltrami; A Deptala; Z Darzynkiewicz; P Anversa
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Senescence-associated alterations of cytoskeleton: extraordinary production of vimentin that anchors cytoplasmic p53 in senescent human fibroblasts.

Authors:  Koji Nishio; Akira Inoue
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

5.  Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells.

Authors:  Samson Amos; Patrick M Martin; Gregory A Polar; Sarah J Parsons; Isa M Hussaini
Journal:  J Biol Chem       Date:  2004-12-23       Impact factor: 5.157

Review 6.  Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.

Authors:  Floris P Barthel; Kevin C Johnson; Pieter Wesseling; Roel G W Verhaak
Journal:  Neurol Clin       Date:  2018-08       Impact factor: 3.806

7.  Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

Authors:  Matthias Simon; Christian Simon; Gertraud Köster; Volkmar H J Hans; Johannes Schramm
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

8.  PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer.

Authors:  Jasmine Allen; Juan Wang; Olga Yu Zolotarskaya; Amrita Sule; Sajjad Mohammad; Shukaib Arslan; Kenneth J Wynne; Hu Yang; Kristoffer Valerie
Journal:  J Control Release       Date:  2020-02-03       Impact factor: 9.776

Review 9.  The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.

Authors:  S M Ivanchuk; S Mondal; P B Dirks; J T Rutka
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

10.  Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).

Authors:  J Mitra; C Y Dai; K Somasundaram; W S El-Deiry; K Satyamoorthy; M Herlyn; G H Enders
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.